CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
Headache
; 58(1): 78-87, 2018 Jan.
Article
in En
| MEDLINE
| ID: mdl-29131327
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
C-Reactive Protein
/
Serum Amyloid P-Component
/
Calcitonin Gene-Related Peptide
/
Botulinum Toxins, Type A
/
Migraine Disorders
/
Neuromuscular Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Headache
Year:
2018
Type:
Article
Affiliation country:
Spain